Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Central neuroblastoma
CUI: C0700095
Disease: Central neuroblastoma
0.050 GeneticVariation BEFREE Our findings revealed that rs110419 and rs2168101 polymorphisms were significantly associated with a decreased risk of NB in all genetic models. 31830377 2020
Central neuroblastoma
CUI: C0700095
Disease: Central neuroblastoma
0.050 GeneticVariation BEFREE We found that the rs110419 A > G polymorphism was associated with a significantly decreased neuroblastoma</span> risk (AG vs. AA: adjusted OR = 0.65, 95% CI = 0.47-0.91; GG vs. AA: adjusted OR = 0.58, 95% CI = 0.36-0.91; AG/GG vs. AA: adjusted OR = 0.63, 95% CI = 0.46-0.86), and the protective effect was more predominant in children of age > 18 months, males, subgroups with tumor in adrenal gland and mediastinum, and patients in clinical stages III/IV. 27009839 2016
Central neuroblastoma
CUI: C0700095
Disease: Central neuroblastoma
0.050 GeneticVariation BEFREE <b>Results:</b> Significant associations with neuroblastoma risk were found for four (rs110419, rs4758051, rs10840002, and rs2168101) out of the five polymorphisms. 30406033 2018
Central neuroblastoma
CUI: C0700095
Disease: Central neuroblastoma
0.050 GeneticVariation BEFREE We also confirmed that rs6939340 A>G (G versus A: OR=1.30, 95% CI=1.13-1.50) and rs110419 G>A (A versus G: OR=1.37, 95% CI=1.19-1.58) were associated with increased neur</span>oblastoma risk for all subjects. 29024823 2017
Central neuroblastoma
CUI: C0700095
Disease: Central neuroblastoma
0.050 GeneticVariation BEFREE A major haplotype, ATC, containing rs204926, rs110420, and rs110419, conferred a significant increase in risk for NB (OR = 1.82, 95% CI: 1.41-2.36, adjusted P < 0.001). 26030754 2015